Ignite Creation Date:
2024-05-06 @ 4:05 PM
Last Modification Date:
2024-10-26 @ 2:03 PM
Study NCT ID:
NCT04863079
Status:
UNKNOWN
Last Update Posted:
2021-04-28
First Post:
2021-04-26
Brief Title:
Pembrolizumab in Post Radical Operation ESCC Patients With Lymph Node Positive KEYSTONE-004
Sponsor:
Tianjin Medical University Cancer Institute and Hospital
Organization:
Tianjin Medical University Cancer Institute and Hospital
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-05-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2022-04-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-04-30
Completion Date Type:
ESTIMATED
First Submit Date:
2021-04-26
First Submit QC Date:
April 26 2021
Study First Post Date:
2021-04-28
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-04-26
Last Update Post Date:
2021-04-28
Last Update Post Date Type:
ACTUAL